May 2003
Volume 44, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2003
Contrast Enhanced MRI Studies of Blood Retinal Barrier Damage in the Diabetic Rat
Author Affiliations & Notes
  • B.A. Berkowitz
    Anatomy & Cell Biology and Ophthalmology, Wayne State Univ School of Med, Detroit, MI, United States
  • R.L. Roberts
    Anatomy & Cell Biology, Wayne State Univ School of Med, Detroit, MI, United States
  • H. Luan
    Anatomy & Cell Biology, Wayne State Univ School of Med, Detroit, MI, United States
  • J. Levy
    Anatomy & Cell Biology, Wayne State Univ School of Med, Detroit, MI, United States
  • X. Mao
    Cancer Research, Merck Research Laboratories, West Point, PA, United States
  • K.A. Thomas
    Cancer Research, Merck Research Laboratories, West Point, PA, United States
  • Footnotes
    Commercial Relationships  B.A. Berkowitz, Merck F; R.L. Roberts, None; H. Luan, Merck F; J. Levy, Merck F; X. Mao, Merck E; K.A. Thomas, Merck E.
  • Footnotes
    Support  Merck, NIH Grant EY10221, Juvenile Diabetes Research Foundation, Research to Prevent Blindness
Investigative Ophthalmology & Visual Science May 2003, Vol.44, 3293. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      B.A. Berkowitz, R.L. Roberts, H. Luan, J. Levy, X. Mao, K.A. Thomas; Contrast Enhanced MRI Studies of Blood Retinal Barrier Damage in the Diabetic Rat . Invest. Ophthalmol. Vis. Sci. 2003;44(13):3293.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: To test the hypothesis that damage to the blood retinal barrier is an early event in the course of experimental diabetic retinopathy. Methods: Blood retinal barrier permeability surface product (PS, cm3/min) was measured in urethane anesthetized rats using dynamic contrast (Gd-DTPA) enhanced MRI (DCE-MRI) after either sodium iodate (30 mg/kg, ip) injection, vascular endothelial growth factor (0.5 µg VEGF/2 ul, intravitreally, 6 hr prior) or vehicle (2 µl, HSA) injection, or in 2 and 4 mo diabetic (and control) rats. PS values in all groups were adjusted for incoherent baseline noise as measured in the control animals. Results: In non-injected and HSA injected control rats, BRB PS was 0 + 0.2 x 10-6 cm3/min (mean + SEM, n = 16). BRB PS in sodium iodate treated rats exhibiting BRB damage (17.8 + 2.7 x 10-6 cm3/min, n = 7) was significantly different (P < 0.05) from the control PS. A linear relationship was found between average vitreous signal enhancement (E) and Gd-DTPA dose (E = -1.5 + 518 (GAD DOSE), r = 0.98, P << 0.05). In VEGF injected eyes, BRB PS value (5.0 + 1.5 x 10-6 cm3/min, n = 5) was significantly different (P < 0.05) from the control PS (0 + 0.2 x 10-6 cm3/min). BRB PS in 2 and 4 mo diabetic rats (-0.2 + 0.2 x 10-6 cm3/min, n = 5 and -0.3 + 0.3 x 10-6 cm3/min, n = 5, respectively) were not significantly different (P > 0.05) from controls (0 + 0.2 x 10-6 cm3/min). Conclusions: DCE-MRI provides a non-invasive and precise quantitative measure of BRB PS in rats. These data do not support the hypothesis that damage to the BRB occurs early in the time course of diabetes in the rat.

Keywords: animal model • imaging methods (CT, FA, ICG, MRI, OCT, RTA, S • blood supply 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×